[PLX] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -2,641.56%
YoY- -56.89%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 10,790 14,248 663 7,526 4,670 5,846 3,707 19.47%
PBT -4,437 -3,560 -15,544 -11,437 -7,290 -3,820 -8,010 -9.36%
Tax 118 34 230 8 268 17 49 15.75%
NP -4,437 -3,560 -15,544 -11,437 -7,290 -3,820 -8,010 -9.36%
Tax Rate - - - - - - - -
Total Cost 15,227 17,808 16,207 18,963 11,960 9,666 11,717 4.45%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -41.12 -24.99 -2,344.49 -151.97 -156.10 -65.34 -216.08 -24.13%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.14 -0.24 -1.05 -0.86 -0.07 -0.04 -0.09 7.63%
EPS Diluted -0.14 -0.24 -1.05 -0.86 -0.07 -0.04 -0.09 7.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.